Masonic Cancer Center, University of Minnesota
The following funding news and opportunities were collected recently by Cancer Center Pre-Award Services and published in Cancer Center Update, a weekly e-newsletter for members and staff.
Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.
Translational Tobacco Use Research Center (TTURC) Pilot Grants Program
Deadline: April 24, 2007
The purpose of the TTURC Pilot Grants Program is to provide rapid access to seed money to support innovative studies aimed at reducing the harm from tobacco dependence, or strategies to reduce tobacco use among populations that have been refractory to smoking cessation efforts. Proposals may involve any level of inquiry, e.g. molecular, genetic, preclinical, clinical, epidemiologic or public policy. More information and application instructions for this and other pilot grants available through the Cancer Center are available on the Web site.American Cancer Society Institutional Research Grant
Deadline: April 16, 2007
Amount: Up to $30,000
This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, cancer immunology and immunotherapy. Applications may be obtained by contacting LeAnn Micek, 612-626-1926, micek003@umn.edu.
2007 Cancer Center Internal Grants Program
Deadline: April 24, 2007, 4:30 p.m.
Visit the Internal Grants Program Web page for more information and application instructions for the Brainstorm Awards, Cancer Population Sciences Awards, Translational Breast Cancer Research Awards, Translational Sarcoma Cancer Research Award, and Transdisciplinary Tobacco Use Research Center Pilot Grants Program.American Cancer Society Institutional Research Grant (see March 27)
Avon-NCI "Progress for Patients" (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer
Deadline: April 27, 2007
The National Cancer Institute announces the 2007 "Avon-NCI Progress for Patients" (PFP) Awards Program: A Special Public-Private Initiative in Early Phase Clinical Interventions and Biomarkers in Breast Cancer supported by a partnership between the Avon Foundation and the National Cancer Institute (NCI). All NCI-designated Cancer Centers are eligible to apply for a competitive supplement proposing projects corresponding to at least one category from the following types of studies:
- Phase I, II, and/or I/II treatment trials with any novel or previously approved agents;
- Risk assessment or prevention studies involving humans;
- Validation testing of a biomarker(s) in human subjects (this type of study can involve the use of specimens from either a retrospective or prospective trial); and/or
- Imaging studies in early detection, treatment monitoring, and response to therapy.
Projects that are still within the discovery phase or the pre-clinical development stage (e.g., involving toxicity screens on animals), or that focus on technology development, are not eligible for this funding mechanism. Additionally, funds from this program are not intended to create pilot or feasibility data for R01 or other applications.
Proposals must be submitted by the Principal Investigator of NCI Cancer Center Support Grants. PI's who are interested in submitting a proposal should contact Doug Yee at yeexx006@umn.edu by the end of March. To read the entire program announcement visit the NIH Web site.
American Cancer Society Institutional Research Grant (See March 27)
American Cancer Society Institutional Research Grant (See March 27)